Germany· DE-A57-c25644a2de003b4f

Glycylpressin

A terlipressin product containing terlipressin acetate, registered in Germany by Ferring Gmbh. The same ATC class is registered in 15 of our 19 countries.

ATC H01BA04

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedGlycylpressinATCH01BA04REGISTER NO.DE-A57-c25644a2de003b…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Terlipressin is registered in 15 of 19 countries.

Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 9 of them publish a price we can compare per daily dose

Terlipressin · ATC H01BA04

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Terlipressin Acetate
Manufacturer
Ferring Gmbh
Country
Germany (DE)
ATC code
H01BA04
ATC class
Terlipressin
Defined daily dose
12 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terlipressin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terlipressin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Glycylpressin
  • Belgium · Glypressin
  • Bulgaria · Реместип
  • Denmark · Glypressin, Terlipressinacetat Sun
  • Estonia · Glypressin
  • Spain · Glypressin, Terlipresina Altan
  • Finland · Glypressin, Terlipressin Sun
  • France · Glypressine, Terlipressine Altan
  • United Kingdom (Northern Ireland) · Glypressin, Terlipressin Acetate Aft
  • Greece · Glypressin
  • Croatia · Glypressin
  • Ireland · Glypressin
  • Iceland · Glypressin
  • Italy · Terlipressina Sun
  • Lithuania · Glypressin
  • Luxembourg · Glypressin
  • Latvia · Glypressin
  • Netherlands · Glypressin, Terlipressine Sun
  • Norway · Glypressin
  • Poland · Glypressin, Terlipressin Acetate Altan
  • Portugal · Terlipressina Altan
  • Romania · Glypressin
  • Sweden · Glypressin, Terlipressin Sun
  • Slovenia · Glypressin
  • Slovakia · Glypressin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/32f71566-257a-48c6-b5b1-21d33b63fee3
GET /v1/drugs/32f71566-257a-48c6-b5b1-21d33b63fee3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Terlipressin Acetate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about terlipressin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.